Profile data is unavailable for this security.
About the company
Circa Group AS is a Norway-based renewable chemicals company. The Company converts biomass into advanced bio-based chemicals using its proprietary Furacell process. The product portfolio is under development, and includes flavorings, biopolymers and bio-solvents such as Cyrene, an alternative to traditional polar aprotic solvents, which is produced in one step from platform biomolecule levoglucosenone. Cyrene, derived from Levoglucosenone (LGO), is greener, safer and often performs better than traditional toxic solvents used in paints, coatings, battery and textile applications as well as many more industrial processes. Circa Group AS has several subsidiaries, including Circa Sustainable Chemicals Pty Ltd, Circa Sustainable Chemicals SAS, Circa Sustainable Chemicals BV and Circa Group Pty. Ltd.
- Revenue in NOK (TTM)18.77m
- Net income in NOK-72.03m
- Incorporated2020
- Employees17.00
- LocationCirca Group ASKarenslyst alle 53OSLO 0279NorwayNOR
- Phone+47 22512020
- Websitehttps://circa-group.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sprint Bioscience AB | 69.41m | 8.91m | 106.35m | 36.00 | 11.94 | 4.24 | 11.23 | 1.53 | 0.1256 | 0.1256 | 0.9791 | 0.3538 | 1.58 | -- | 11.45 | 2,441,286.00 | 20.29 | -71.22 | 43.20 | -113.71 | 80.06 | 62.75 | 12.83 | -110.22 | -- | -- | 0.00 | -- | 60,725.30 | 22.99 | 99.27 | -- | -26.02 | -- |
| Spago Nanomedical AB (publ) | 1.49m | -36.13m | 108.19m | 12.00 | -- | 2.01 | -- | 72.68 | -0.3129 | -0.3129 | 0.0113 | 0.1525 | 0.0324 | -- | 9.91 | 112,769.20 | -78.60 | -20.19 | -93.27 | -20.97 | -5.25 | -- | -2,426.88 | -4,853.45 | -- | -- | 0.00 | -- | 14.14 | -- | -7.72 | -- | -- | -- |
| StenoCare A/S | 6.28m | -25.74m | 109.78m | 9.00 | -- | 3.20 | -- | 17.47 | -1.13 | -1.13 | 0.2674 | 1.22 | 0.1285 | -- | 2.94 | -- | -52.62 | -28.16 | -70.34 | -35.47 | -- | -- | -409.55 | -371.06 | 1.04 | -5.56 | 0.2362 | -- | -16.30 | -- | -7.77 | -- | -- | -- |
| Isofol Medical AB (publ) | 0.00 | -31.64m | 112.84m | 4.00 | -- | 0.9838 | -- | -- | -0.1964 | -0.1964 | 0.00 | 0.6993 | 0.00 | -- | -- | 0.00 | -20.49 | -66.73 | -24.10 | -88.27 | -- | -- | -- | -1,023.62 | -- | -- | 0.00 | -- | -94.37 | -- | 76.80 | -- | -- | -- |
| New Nordic Healthbrands AB | 546.11m | -10.33m | 114.49m | 70.00 | -- | 1.08 | -- | 0.2097 | -1.64 | -1.64 | 86.81 | 16.86 | 2.16 | 1.84 | 4.96 | 7,367,219.00 | -4.09 | 5.36 | -9.16 | 10.55 | 65.32 | 67.30 | -1.89 | 2.38 | 0.8584 | -4.44 | 0.2821 | 47.96 | 9.51 | 6.28 | -119.41 | -- | 28.36 | -- |
| Odi Pharma AB (publ) | 15.03m | -1.69m | 119.00m | -- | -- | 33.59 | -- | 7.92 | -0.1097 | -0.1097 | 0.9727 | 0.2293 | 1.36 | 18.13 | 3.94 | -- | -15.36 | -- | -39.25 | -- | -25.26 | -- | -11.27 | -- | 1.26 | -2.31 | 0.00 | -- | -55.44 | -- | 4.67 | -- | -- | -- |
| ExpreS2ion Biotech Holding AB | 7.89m | -79.15m | 121.92m | 18.00 | -- | 1.24 | -- | 15.46 | -1.33 | -1.33 | 0.129 | 0.8696 | 0.0821 | -- | 4.87 | 298,730.80 | -82.36 | -63.54 | -113.92 | -75.88 | -132.91 | -1.94 | -1,003.55 | -524.31 | -- | -- | 0.0055 | -- | 43.07 | -0.1561 | 22.94 | -- | 19.90 | -- |
| Coegin Pharma AB | 0.00 | -28.41m | 123.12m | 0.00 | -- | 9.31 | -- | -- | -2.65 | -2.65 | 0.00 | 0.6403 | 0.00 | -- | -- | -- | -125.24 | -122.02 | -201.53 | -154.70 | -- | -- | -- | -28,466.75 | -- | -170.65 | 0.00 | -- | -- | -- | 20.60 | -- | -- | -- |
| Toleranzia AB | 0.00 | -6.40m | 127.67m | 7.00 | -- | 0.8232 | -- | -- | -0.0405 | -0.0405 | 0.00 | 0.775 | 0.00 | -- | -- | 0.00 | -4.50 | -7.45 | -4.65 | -7.78 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 11.79 | -- | 63.90 | -- |
| Circa Group AS | 18.77m | -72.03m | 130.88m | 17.00 | -- | 0.3809 | -- | 6.97 | -0.6611 | -0.6611 | 0.1698 | 2.81 | 0.0403 | 5.46 | 0.9139 | 1,104,253.00 | -15.46 | -- | -19.96 | -- | 75.64 | -- | -383.72 | -- | 0.7097 | -- | 0.00 | -- | 41.73 | -- | -0.0491 | -- | -- | -- |
| Enorama Pharma AB | 680.35k | -43.12m | 136.33m | 5.00 | -- | 5.69 | -- | 200.38 | -1.03 | -1.03 | 0.0163 | 0.4271 | 0.0184 | 0.7583 | 0.6384 | 134,000.00 | -116.48 | -73.56 | -184.45 | -104.85 | -635.07 | 43.36 | -6,338.66 | -557.42 | 0.4626 | -605.70 | 0.02 | -- | -80.17 | -23.71 | -6.15 | -- | -- | -- |
| Bioextrax AB publ | 1.65m | -22.50m | 145.54m | -- | -- | 7.83 | -- | 88.04 | -0.8034 | -0.8034 | 0.0588 | 0.5315 | 0.0686 | -- | 4.96 | -- | -93.29 | -86.39 | -102.02 | -110.84 | 3.62 | -- | -1,360.93 | -2,119.90 | -- | -- | 0.00 | -- | 420.51 | 24.40 | -15.21 | -- | 56.86 | -- |
| Pila Pharma AB | 1.49m | -10.08m | 151.73m | 1.00 | -- | 22.43 | -- | 102.13 | -0.5304 | -0.5304 | 0.0767 | 0.28 | 0.1513 | -- | 6.11 | 1,463,020.00 | -102.68 | -108.88 | -122.66 | -121.45 | -127.88 | -42.67 | -678.73 | -1,577.64 | -- | -159.47 | 0.104 | -- | -22.21 | -- | 62.92 | -- | -- | -- |
| Xintela AB | 382.82k | -50.00m | 155.46m | -- | -- | -- | -- | 406.08 | -0.1217 | -0.1217 | 0.0008 | -0.0136 | 0.0193 | -- | 0.0447 | -- | -252.59 | -181.06 | -- | -391.61 | 100.00 | -- | -13,061.54 | -235,894.00 | -- | -49.47 | -- | -- | -- | -45.54 | 18.32 | -- | -61.47 | -- |
| Lipidor AB | 88.34k | -11.77m | 156.83m | -- | -- | -- | -- | 1,775.25 | -0.1049 | -0.1049 | 0.0008 | -0.0817 | 0.0122 | -- | 0.19 | -- | -162.65 | -59.41 | -- | -75.10 | -- | -- | -13,322.99 | -643.36 | -- | -- | -- | -- | 73.33 | -20.33 | 72.24 | -- | -- | -- |
Data as of Jun 14 2024. Currency figures normalised to Circa Group AS's reporting currency: Norwegian Krone NOK
4.44%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Robeco Schweiz AGas of 30 Apr 2024 | 2.20m | 1.80% |
| First Fondene ASas of 30 Jun 2023 | 2.11m | 1.73% |
| Goldman Sachs Asset Management LPas of 31 May 2023 | 941.10k | 0.77% |
| Forte Fondsforvaltning ASas of 31 May 2024 | 125.00k | 0.10% |
| Storebrand Asset Management ASas of 31 Jan 2024 | 36.06k | 0.03% |
| Fj�rde AP-fondenas of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2023 - 31 May 2024Source: FactSet Research Systems Inc.
